Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Deep Insight

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 7
Average round size
info
The average size of a deal this fund participated in
$42M
Portfolio companies 6
Rounds per year 7.00
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.14
Exits 1
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Electronics
  • Semiconductor
  • Medical

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Deep Insight:
Typical Co-investors
Deep Insight is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Deep Insight:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
11.2 Capital California, San Francisco, United States
1C Company Moscow, Moscow, Russia
Alphawave group -
Assurance Capital -
BrasilAgro Companhia Brasileira de Propriedades Agricolas -
Bushburg Properties Brooklyn, New York, United States
Centre de Collaboration MiQro Innovation -
Chobe Capital China, Shanghai
FEBO Limited Partnership -
Hoshino Fragment Japan, Tokyo
Rising Capital Beijing, Beijing, China
The Newfoundland and Labrador Association of Technology Industries Canada, Newfoundland, St. John's
The Watermill Group Lexington, Massachusetts, United States
Venture Angels -
Volpe Brown & Whelan -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

MediWound

Biotechnology
Manufacturing
Medical Device
$30M22 Sep 2022 Yavne, HaMerkaz, Israel

TriEye

Automotive
Autonomous Vehicles
Electronics
Hardware
Semiconductor
Sensor
$74M10 Nov 2021 Tel Aviv-Yafo, Tel Aviv District, Israel

Biond Biologics

Biotechnology
Health Care
Pharmaceutical
$15M03 Nov 2021 Misgav Regional Council, North District, Israel

Aviv Scientific

Health Care
Medical
$40M22 Sep 2021 Tel Aviv, Tel Aviv, Israel

Ramon.Space

Aerospace
Computer
Electronics
Machine Learning
Semiconductor
Software
$17M25 May 2021 Palo Alto, California, United States

Rapid Medical

Biotechnology
Health Care
Medical
Medical Device
$50M03 May 2021 Israel, North District, Israel
News
Aviv Scientific Raises $40 Million in Series B Funding to Create the World’s First High Dimensional OMICS Database of the Aging Process

– World leader in research and clinical treatment of age-related cognitive and functional decline to maximize human performance, Aviv Scientific, announced the closing of a oversubscribed Series B funding round.
– Led by Israel’s largest public medical services conglomerate, Danel LTD; Jeff Horing’s Deep Insight Fund; the country’s most successful high-tech angels and entrepreneurs; international longevity and healthspan optimization focused investors; the Series B fundraise will accelerate the global rollout of its network of medical clinics and the development of the Aviv Aging Database.
– The application marked the first-time scientists successfully managed to biologically reverse the aging process in healthy humans, using hyperbaric oxygen therapy to lengthen telomeres and reduce senescent cells while also demonstrating cognitive enhancement in healthy adults.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Deep Insight?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: